Description
Obesity and metabolic syndrome represent a growing global health problem, driven in part by sedentary lifestyles and poor dietary habits. Obesity increases the risk of developing chronic diseases. In particular, obesity and metabolic syndrome are risk factors for kidney disease. Finaly, as a consequence of the current pandemic of obesity and MS, these conditions are highly prevalent in subjects with CKD, a fact that adds extra damage to diseased kidneys.
Scientific evidence increasingly supports the role of lifestyle interventions—especially structured exercise and tailored nutrition—in preventing and managing these interconnected conditions. The integration of exercise and diet into standard care offers a powerful, cost-effective approach to improving patients’ quality of life and long-term prognosis.
This CME of the DOKI project brings together leading experts to explore the latest research and practical applications of lifestyle-based therapies in patients with chronic kidney disease, obesity and diabetes. It emphasizes the urgent need to rethink conventional management of metabolic and renal diseases through a multidisciplinary lens. Participants will examine clinical trials, case studies, and population data highlighting the transformative impact of behavioral interventions.
Course content